Inovio Pharmaceuticals, Inc.

US$1.22As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:INOHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (33.96%)
Div yield —
ROE (409.87%)
Biotechnology
Beta (5Y) 1.73
PE TTM —
TSR TTM (48.30%)
Mkt cap US$205.2M
ROIC (192.15%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.37
12.41%
(77.02%)
Hold 4|1|4|4|8
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.02
0.02
0.02
0.02
19.88%
18.34%
19.01%
13.36%
Revenue$M
13.83
13.42
13.98
13.93
11.19%
3.94%
8.13%
5.48%
Peers (US$205.2M)
Cap (US$)
PE
202.5M
—
203.6M
—
Capital
TTM
5Y
10Y
Leveragex
0.385
0.368
0.358
EBIT/Intx
1.872
0.480
0.499
Own earn%
(9.16)
(21.94)
(31.82)
Sh yield%
9.86
48.23
47.76
Owners
Insiders/Inst%
8.85
52.47
Short interest%
1.45
SBC / revenue%
5.75
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
13
Op margin range%
27–34
$1 testx
0.1
Incr. ROIC%
1